TLR Engagement Induces an Alternate Pathway for BCR Signaling that Results in PKCδ Phosphorylation
The Journal of Immunology · 2024
DOI: 10.4049/jimmunol.2300784 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Naeem Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunobiology, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI. Hauptthemen laut MEDLINE: Protein Kinase C-delta, Signal Transduction, Lipopolysaccharides, Interleukin-4. Die Arbeit nennt 35 Literaturangaben. Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).
Abstract (Originalsprache)
Recently, we reported that preexposure of B cells to IL-4 induced an alternate, signalosome-independent BCR signaling pathway leading to protein kinase C (PKC)δ phosphorylation (pTyr311), which occurs in the membrane compartment. This is considered to represent a form of receptor crosstalk and signal integration. Unlike the classical BCR signaling pathway, Lyn kinase is indispensable for BCR-induced downstream events in the alternate pathway. Our previous report that alternate BCR signaling leading to ERK phosphorylation is triggered by LPS and PAM3CSK4 (much like IL-4) raises the possibility that other signaling outcomes such as PKCδ phosphorylation might be similarly affected. To explore the range of mediators capable of producing an alternate pathway for BCR signaling, we examined PKCδ translocation and phosphorylation in LPS- and PAM3CSK4-treated B cells stimulated by anti-Ig. We found that LPS and PAM3CSK4 alter the signaling pathway used by the BCR to produce PKCδ phosphorylation. As with IL-4, elements of the signalosome are not needed for PKCδ phosphorylation when BCR triggering occurs after LPS and PAM3CSK4. However, with LPS and PAM3CSK4, anti-Ig–induced phosphorylation of PKCδ takes place in the cytosol, in contrast to the IL-4–induced alternate pathway, wherein PKCδ phosphorylation occurs in the membrane. Furthermore, the BCR signaling pathway induced by LPS and PAM3CSK4 differs from that induced by IL-4 by not requiring Lyn. Thus, an alternate, signalosome-independent BCR signaling pathway for PKCδ phosphorylation is induced by TLR agonists but differs in important ways from the alternate pathway induced by IL-4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Immunobiology, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI.
- Department of Laboratory Medicine, University of California, San Francisco School of Medicine, San Francisco, CA.
- Department of Investigative Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI.
ORCID-Profile: Naeem Khan, Clifford A Lowell, Thomas L Rothstein
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
Zitieren
APA
Khan, N., Hu, Y., Lowell, C. A., & Rothstein, T. L. (2024). TLR Engagement Induces an Alternate Pathway for BCR Signaling that Results in PKCδ Phosphorylation. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300784
Vancouver
Khan N, Hu Y, Lowell CA, Rothstein TL. TLR Engagement Induces an Alternate Pathway for BCR Signaling that Results in PKCδ Phosphorylation. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300784
BibTeX
@article{Khan2024,
author = {Khan, Naeem and Hu, Yongmei and Lowell, Clifford A and Rothstein, Thomas L},
title = {TLR Engagement Induces an Alternate Pathway for BCR Signaling that Results in PKCδ Phosphorylation},
journal = {The Journal of Immunology},
year = {2024},
doi = {10.4049/jimmunol.2300784}
}
EUVIMED